Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: Implications for rational design of typhoid fever vaccines
- 2 December 2008
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 26 (51), 6639-6644
- https://doi.org/10.1016/j.vaccine.2008.09.030
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Postmarketing Safety Surveillance for Typhoid Fever Vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002Clinical Infectious Diseases, 2004
- Typhoid FeverThe New England Journal of Medicine, 2002
- Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18Nature, 2001
- Complete genome sequence of Salmonella enterica serovar Typhimurium LT2Nature, 2001
- Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicityBMJ, 1998
- Identification of two targets of the type III protein secretion system encoded by the inv and spa loci of Salmonella typhimurium that have homology to the Shigella IpaD and IpaA proteinsJournal of Bacteriology, 1995
- Relationship between evolutionary rate and cellular location among the Inv/Spa invasion proteins of Salmonella enterica.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Genetic map of Salmonella typhimurium, edition VIII.Microbiological Reviews, 1995
- Lymphocytic Proliferative Response to Outer-Membrane Proteins Isolated fromSalmonellaMicrobiology and Immunology, 1993
- Anti-IFN-γ-treated mice — a model for testing safety of live Salmonella vaccinesVaccine, 1992